Product Liability Archive » June, 2012

Product Liability - June, 2012

254 articles

• Maclaren To Cover Claims Against Its Bankrupt Distributor
• Roche To Pay $18M Damages In Accutane Suit
• Feds Ask 4th Circ. To Uphold Ex-Massey Official's Conviction
• Acid Reflux Device Maker Beats Class Cert. In Row Over Ads
• Law360's Global 20 Firms Open Up New Frontiers
• Grubb & Ellis Allows Cleanup Workers' 9/11 Suits To Proceed
• Merger Puts Travelers On Hook For Popcorn Lung Suits: Court
• FDA Warns GSK's Zofran May Cause Abnormal Heart Rhythm
• Union Carbide Can't Escape Asbestos Wrongful Death Suit
• Differential Diagnosis Can't Establish 'General Causation'
• FDA Panel Calls For More Warnings On Metal Hip Implants
• 3rd Circ. Revives Suit Against GSK Over Avandia Injury Costs
• 11th Circ. Lets Home Depot Off Hook In Warning Label Dispute
• 'Bath Salts' Drug Ban Heads To Obama's Desk
• Travelers Must Cover $375M Asbestos Deals, 2nd Circ. Hears
• BioSante Sued Again Over Female Libido Drug Disappointment
• Fla. Smoker's $37M Win Against Philip Morris Upheld
• Pfizer Avoids Off-Label Marketing Suit Over Geodon, Zyvox
• Generic-Drug Users Can't Pin Brand-Name Cos., NJ Court Says
• Frenville — Gone But Not Forgotten In The 3rd Circ.
• Scotts Miracle-Gro Faces RICO Suit Over Tainted Bird Food
• Tort Is Not An Option In Ill. Employee Asbestos Exposure
• Ecuadoreans Seek Chevron's Brazilian Assets Over $18B Award
• DePuy, Others Urge FDA Not To Lump Together Hip Implants
• 9/11 Families Tell 2nd Circ. Bin Laden Firm Belongs In MDL
• Citigroup Asks 2nd Circ. To End 7 WTC Legal Fees Suit
• FDA Says Amylin Hid Diabetes Drug Safety Data
• Arena's Belviq 1st Obesity Drug To Get FDA's Nod Since 1999
• FAA Seeks More Inspections Of Cracks In Boeing Planes
• FDA Moves Forward On Study Of Drug Ad Offers
• Union Carbide Evades Bhopal Chemical Exposure Suit
• No Duty To Warn For 'Nonconventional' Alcohol Beverages
• Dissecting Da Silva: There Is A Science To It
• Admiral Insurance Settles PCL Construction Coverage Row
• FDA Questions Safety Of Rockstar Energy Booster
• Comcast Case Gives Justices A Chance To Expand On Dukes
• FDA User Fee Bill Breezes Through Congress
• Obama Vows Veto For Spending Bill That Shorts FDA By $700M
• Public Citizen Pushes FDA To Deny Diet Pill Approval
• Enviro Group Asks 5th Circ. To Reinstate Deepwater Claims
• W.Va. AG Sues 14 Drug Distributors Tied To Painkiller Abuse
• FDA Rips Covidien Response To Surgery Device Safety Issues
• Liberty Mutual Must Back Alcoa In Homeowners' 'Red Dust' Suit
• Sens. Propose New Licensing Rules For Radiation Techs
• Volvo Settlement Over Faulty SUV Engines Wins Judge's Nod
• Lessons For Defendants Facing Motions To Amend
• Calif. Panel Puts Brakes On Driverless Car Bill Vote
• 7th Circ. Sinks Safeco's Bid To Escape Water Damage Claims
• Justices Won't Hear Shaw Workers' Radioactive Exposure Suit
• Post-Mensing Landscape A Wasteland For Plaintiffs
• Nissan Japan Seeks To Exit Transmission Defect Class Action
• Liberty Mutual Looks To Duck Covering Linn In Pollution Case
• Merck Pays $10M To Exit ERISA Class Action Over Vytorin
• Chesapeake Pays $1.6M To Settle Water Contamination Suit
• Merck Hit With Antitrust Class Action Over Vaccine Data
• Metal Hip Implant Safety Studies Lacking, FDA Says
• Top Dem Blasts NRC Response To Entergy Nuke Plant Leak
• High Court To Hear Comcast's Class Cert. Appeal Post-Dukes
• High Court Turns Down $5.6M Kia Brake Defect Appeal
• FDA Again Delays Approval Of Pfizer-BMS Anti-Clotting Drug
• Supreme Court Won't Touch $926M Dow Contamination Suit
• A Look At Recent Developments At The CPSC
• GM Recalls 413,000 Chevy Cruzes Over Engine Fire Risk
• Big Tobacco Extinguishes Calif. Cigarette Tax Measure
• Ind. Stage Collapse Victims Get $7.2M From Rigging Planners
• DC Circ. Boots Patton Boggs Row With Gibson In Chevron Case
• Generics Cos. Escape From Darvocet, Darvon MDL
• GCs Name Law Firms With Top Shelf Brands
• BASF Wants $30M From Contractor Over Texas Plant Shutdown
• Feds Probe Ford Over Alleged SUV Power Steering Problems
• FDA Hit With FOIA Suit Seeking Livestock Antibiotics Data
• DC Circ. Upholds More Stringent EPA Lead Paint Rule
• FBI To Probe Hospital That May Have Risked Hep C Outbreak
• In Texas, The Learned Intermediary Doctrine Holds Steady
• Flushmate Recalls More Than 2 Million Toilet Systems
• Allergan Requests Appeal Of Del. Botox Decision
• FDA Supplement Guidance Likely To Remain Onerous, Attys Say
• Hazy Outlook May Push More Insurers To Settle Drywall Claims
• Roche Ignored Drug Safety Reports, EU Watchdog Says
• Whistleblowers Say Merck Falsified Mumps Vaccine Data
• Calif. Jury Awards $48M In Union Carbide Asbestos Case
• Miss., Ala. Ask 5th Circ. To Preserve States' Rights In Spill Suits
• Allstate Spruces Up Defect Suit Over Christmas Tree Blaze
• 5th Circ. Upholds Sanctions Against Law Firm In Tire Case
• FDA To Lower Risk Category For Hemodialysis Devices
• Determining A Product's Defect By Its Primary Use
• Insurers Pay $13M To Settle Chinese Drywall Claims
• 5th Circ. Says Arkema Not Liable For Chronic Injury Claims
• Transocean Says BP's Deepwater Chief Must Submit To Physical
• NYC Defends Flavored Tobacco Ban In 2nd Circ.
• J&J Can't Get New Trial Over $1.2B Ark. Risperdal Fine
• House Panel Looks To Limit FDA Oversight Of Cigars
• House Bill Would Halt New Surface Mines Pending HHS Study
• NY Assembly Passes Fracking Health Study Bill
• FDA Panel Endorses Onyx Pharmaceuticals' Blood Cancer Drug
• FDA User Fee Bill Keeps Rocketing Through Congress
• CPSC Mulls Reforms To Recall System
• Fla. Appeals Court Nixes $6.6M Union Carbide Asbestos Award
• FDA Panel Won't Back Sanofi Blood Thinner For Cancer Patients
• A New Era For Pa. Asbestos Litigation
• Sens. Begin Voting On Amendments To $1T Farm Bill
• Drugmakers Find Much To Love In Final FDA Reform Bill
• Disbarred Attys Must Forfeit Assets Over Fen-Phen Fees
• AMA Support For Bioengineered Food Will Hurt Labeling Drive
• Pfizer Storing Up $330M To Settle Menopause Drug Suits
• Calif. Panel Throws Out Bill Targeting Utility Execs' Bonuses
• Garlock Asbestos Claimants Denied Privileged Docs
• Mo. Appeals Court Overturns Part Of $3M Asbestos Award
• Asbestos Removal Tax Credit Bill Clears NY Senate
• 6th Circ. Won't Give Whirlpool Another Spin In Washer Suit
• 7th Circuit: Opening The Door To Copycat Class Actions
• Calif. Seeks To Update Flammability Rules To Avoid Toxics
• Sanction-Marred Toyota Acceleration Suit Remains Bellwether
• Industry-Backed Drug Tracking System Gone From FDA Bill
• EU Breast Implant Study Won't Help Litigation Targets
• 10th Circ. Puts Brakes On Toyota Faulty Engine Class Action
• Fla. Judge Won't Snuff Nestle Waters' Suit Over Fire Coverage
• Fla. Judge Knocks Down Football Helmet Concussion Suit
• NHTSA To Probe Fire Risk In 1.4M Toyota Vehicles
• Samsonite Yanks Chinese Suitcases Due To Chemical Worries
• A Causation Theory That's Hard To Swallow
• Deepwater MDL Judge Caps Attys' Fees At 25%
• FDA Probe Could Grow To Encompass Fresenius Empire
• FCC To Consider Reviewing Cellphone Radiation Standards
• Wyeth Can't Kick Class Cert. In Canadian Suit Over Premarin
• K&L Gates Adds Product Liability Team In Orange County
• NH Hospital's Hep C Outbreak Sparks AG Probe, Class Action
• Wis. High Court Won't Hear Asbestos Suit Against Abex
• Atty Fees In $5.5M Nutella Deal Left Bad Taste, Consumers Say
• St. Jude Stock Flatlined Amid Recalls, Investors Say
• Asking The Hard Questions In Class Action Litigation
• Health Care Ruling Could Mean Years Of Delay For Biosimilars
• EU Lawmakers Push For Tougher Breast Implant Standards
• Food Safety Amendments Slow Down Senate Farm Bill
• La. Communities Want Deepwater State Law Claims Revived
• Merck Wins Dismissal Of Vioxx False Claims Suit From MDL
• FDA Panel Backs Edwards Heart Valve For Wider Use
• Liberty Mutual Wants Off Hook For Sears Ice Maker Suit
• Judge Won't Reconsider RCRA Claim In Halliburton Suit
• BP Hit With $500B Suit Over Texas Refinery's Emissions
• Safety Regulators Step Up Jeep SUV Fire Risk Probe
• In Pa., 'Any Exposure' Does Not Equal Causation
• Lights, Camera, Courtroom: Lessons From Mike Wallace
• Judge Tosses Guatemalans' STD Suit Against US
• Novartis Defeats Appeal To Bone Drug Bellwether Ruling
• Pfizer Battles 2nd FCA Suit Over Antifungal Drug Promotions
• NAM, Others Want 6th Circ. Rehearing In Whirlpool Suit
• Judge Fries Challenge To Cleveland's Trans Fat Ban
• Report Fingers 2nd St. Jude Device For In-Body Wire Failure
• BP Asks 5th Circ. To Kill Third-Party Deepwater Claims
• FDA Advances Petition To Ban BPA In Formula Packaging
• Payors Urge 1st Circ. To Revive Pfizer Neurontin MDL Claims
• WHO Says Diesel Fumes Cause Lung Cancer
• Honda To Face Civic Tire Defect Claims As Class Action
• Another Approach To The Unsafe Product Exclusion
• Judge Waives Lingering Objection To WR Grace Ch. 11 Plan
• San Diego Utility To Pay $27M To Snuff City's Wildfire Suit
• Calif. Voters Will Decide On GMO Labeling In November
• Toyota Might Take Chances On Sanction-Laden Bellwether
• Panel OKs Bill To Align Calif. False Claims Law With US Law
• Additional Insureds' Chances At Coverage Limited In NY
• JPML Won't Merge 5 Louisiana-Pacific Siding Defect Suits
• Massey Settlement Heads Off Trial In Water Pollution Suit
• DC Circ. Nixes Chevron's Doc Access In $18B Ecuador Case
• NY Enlists Docs, Pharmacists In Rx Drug Crackdown
• Novartis Asks 4th Circ. To Block $1M Aredia, Zometa Verdict
• FSMA's Potential Impact, Part 2: Title And Risk Of Loss
• BP Spill Judge Won't Recuse Himself In Obstruction Case
• 9/11 Cancer Coverage Rule Could Imperil Fund's Longevity
• Edwards Valve Comparable To Traditional Surgery, FDA Says
• Arch, Contractor Settle Construction Defect Coverage Suit
• NJ High Court Will Weigh In On Prison Defect Suit
• SEC Should Probe Chevron Over $18B Ruling, House Rep. Says
• Allergan Can't Kick Investor Suit Over $600M Botox Settlement
• EU May Relax Rules On Unapproved GM Food
• BP Denied Access To Deepwater Horizon Documents
• FDA Warnings Can Be Fought In Court, Supreme Court Told
• Summary Judgment Lessons From Mims V. Wright
• High Court To Weigh In On Amgen Class Cert. Quarrel
• J&J Announces $600M Hit To Pay For Drug Settlements
• Toyota Loses Bid To Nix Acceleration Case From State Queue
• Texas High Court Adopts Intermediary Rule In Drug Cases
• Canadian PM Proposes Tougher Food Safety Law
• Honda Wipes Out Paint Defect Class Action
• Quebec Seeks $60B From 10 Tobacco Cos. For Health Costs
• Judge Greenlights Miners' Fraud Suit Against Jackson Kelly
• 9/11 Responders To Get Cancer Coverage Under Proposed Rule
• Pennzoil, NAPA, Big Lots Face Carcinogen Exposure Suit
• Developer Says BP Oil Spill Ruined Housing Complex Sales
• Corning Win To Group Asbestos Claims May Help NY Insureds
• Feds Ignore Lessons Of GSK Obstruction Case, Attys Say
• Exide Settles Lead Emissions Dispute With Texas City
• Gilead Stalled On HIV Prevention Approval For Truvada
• Conducting A Product Liability Risk Assessment
• Insurers Want Liability Cap For Commercial Spaceflight
• EPA Bending Data To Justify Fracking Regs, GOP Rep. Says
• CR Bard Picks Up Bellwether Win In Vein Filter Defect Suit
• Ex-NFL Players' Brain Injury Suits Combined In Pa.
• DOE Fights BP's Bid For Agency Emails In Deepwater MDL
• Travelers Can't Shake Welding Co.'s Injury Claims Suit
• Enviros Sue EPA Over Lack Of Lead Bullet Regulations
• Garlock Asbestos Committee Can't Act As Trustee
• Cargill Can't Shake Counterclaims In E. Coli Suit
• Connecting Off-Label Marketing To Use: Not Quite A To B
• Black & Veatch Sues Insurers Over AEP Power Plant Defects
• Alien Tort Law's Reach Limitless, Nigerians Tell High Court
• WR Grace To Pay $20M To Settle Mont. Asbestos Claims
• 6th Circ. Lets Novartis Off Hook In Bone Drug Liability Suit
• Hinshaw & Culbertson Adds Litigation Pro To Miami Office
• Doctors Don't Properly Store Kids' Vaccines, HHS Says
• Cascade Grain Settles $4M Contaminated Ethanol Claim
• House Panel OKs Bill Blocking Court Bans On GE Crops
• Stryker Offers $33M To End DOJ Probe Into Knee Product
• FDA Must Strengthen Reviews For Risky Devices: FDA Head
• Tripping Up Defendants With Bootstrap Reasoning
• Mich. Courts Can't Nix Policy Limits Automatically: 6th Circ.
• 9th Circ. Restarts Toyota Owners' Brake Defect Case
• Federal Insurance Wants Off Hook For PetArmor Defense
• FDA Warns Siemens Over Biochemical Device Design
• No Magic Can Save Disney Health Label From Scrutiny
• J&J Tells Judge It Will Stop Selling Vaginal Implants
• FDA Must Act On Livestock Antibiotics, Judge Says
• FDA Should Boost Training For Device Reviewers: Report
• Judge Pares Defenses Deflecting Wildfire Blame To USFS
• Judge Trims Suit Alleging Faulty Rolls-Royce Engines
• La. Votes To Reserve Deepwater Fines For Restoration Work
• Pfizer Boosts Quigley Asbestos Funds In New Ch. 11 Plan
• Pittsburgh Corning Blasts Insurers' Discovery Request
• For Whom The Court Tolls
• $7.8B Deepwater MDL Settlement Heads Into Claims Stage
• 8th Circ. Reinstates Investors' Claims Against KV Pharma
• Vt. Joins Push To Strengthen Consumer Protections
• NFL Can Punish Saints Players Over Bounties, Arbitrator Says
• Egg Co. Faces Suit Over Salmonella Outbreak Death
• Smith & Nephew Hip Problems May Persist Beyond Recall
• 5th Circ. Asked To Revive Deepwater Firefighting Boat Suit
• Electrolux Can't Evade Heat In State Farm Dryer Fire Suit
• Health Groups Want Deadline For Long-Stalled Device Rules
• Dole, Shell, Others Exposed Banana Workers To DBCP: Suit
• The Increasing Importance Of Timely Reports To CPSC
• FDA Warns Of Harmful Unlisted Drugs In Mexican Supplement
• Judge Grants New Trial In $212M Allergan Botox Suit
• Pharmacists Urge Congress Not To Restrict Hydrocodone Use
• 8th Circ. Absolves Drugmakers In Mirapex Liability Suit
• Chevron Wants High Court To Lift $18B Ecuadorean Judgment
• Goldman, Tishman Move To Nix Ice Rink Owner's Building Suit
• J&J Wins Reversal Of Expert Restriction In Pelvic Mesh Suits
• 4 Tobacco Cos. Face $55M Damages In Landmark Engle Case
• Pharmacists Ask FDA For Biosimilar Substitution Power
• ConAgra Blast Victims Win $180M Jury Award
• Plastics Co. Sues Insurers Over Superfund Liability Coverage
• Removing Product Liability, Mass Tort Cases To Fed Court
• 'Shape Up' Maker Tells 5th Circ. Chubb Owes Coverage
• Pros And Cons Of Computer-Assisted Review